HilleVax Statistics

Total Valuation

HilleVax has a market cap or net worth of $88.01 million. The enterprise value is -$135.06 million.

Market Cap	88.01M
Enterprise Value	-135.06M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, before market open.

Earnings Date	Aug 12, 2024
Ex-Dividend Date	n/a

Share Statistics

HilleVax has 49.72 million shares outstanding. The number of shares has increased by 28.36% in one year.

Shares Outstanding	49.72M
Shares Change (YoY)	+28.36%
Shares Change (QoQ)	+1.73%
Owned by Insiders (%)	17.14%
Owned by Institutions (%)	81.36%
Float	21.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.37
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.92, with a Debt / Equity ratio of 0.21.

Current Ratio	10.92
Quick Ratio	n/a
Debt / Equity	0.21
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-52.75

Financial Efficiency

Return on equity (ROE) is -56.20% and return on invested capital (ROIC) is -53.13%.

Return on Equity (ROE)	-56.20%
Return on Assets (ROA)	-43.70%
Return on Capital (ROIC)	-53.13%
Revenue Per Employee	n/a
Profits Per Employee	-$1.59M
Employee Count	90
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.82% in the last 52 weeks. The beta is 0.79, so HilleVax's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	-87.82%
50-Day Moving Average	11.39
200-Day Moving Average	13.70
Relative Strength Index (RSI)	16.33
Average Volume (20 Days)	2,432,794

Short Selling Information

The latest short interest is 1.67 million, so 3.37% of the outstanding shares have been sold short.

Short Interest	1.67M
Short Previous Month	1.55M
Short % of Shares Out	3.37%
Short % of Float	7.96%
Short Ratio (days to cover)	6.95

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-154.18M
Pretax Income	-143.51M
Net Income	-143.51M
EBITDA	-138.33M
EBIT	-140.84M
Earnings Per Share (EPS)	-$3.30

Full Income Statement

Balance Sheet

The company has $274.37 million in cash and $51.31 million in debt, giving a net cash position of $223.07 million or $4.49 per share.

Cash & Cash Equivalents	274.37M
Total Debt	51.31M
Net Cash	223.07M
Net Cash Per Share	$4.49
Equity (Book Value)	238.91M
Book Value Per Share	4.81
Working Capital	255.35M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$103.83 million and capital expenditures -$7.92 million, giving a free cash flow of -$111.75 million.

Operating Cash Flow	-103.83M
Capital Expenditures	-7.92M
Free Cash Flow	-111.75M
FCF Per Share	-$2.31

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HilleVax does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.36%
Shareholder Yield	-28.36%
Earnings Yield	-163.06%
FCF Yield	-126.98%

Analyst Forecast

The average price target for HilleVax is $2.50, which is 41.24% higher than the current price. The consensus rating is "Hold".

Price Target	$2.50
Price Target Difference	41.24%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-21.56%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1